Copyright
©The Author(s) 2025.
World J Exp Med. Sep 20, 2025; 15(3): 108034
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.108034
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.108034
Table 6 Diagnostic performance of microRNAs and other tumor biomarkers for differentiating between breast cancer patients (grade II vs grade III)
Parameters | Area under the curve | Cut-off value | Sensitivity (%) | Specificity (%) | P value | 95%CI |
MiR-21 | 0.997 | 3.79 | 95.83 | 100.00 | 0.001 | 0.921-1.000 |
MiR-221 | 0.843 | 2.11 | 75.00 | 96.00 | 0.001 | 0.711-0.931 |
MiR-1246 | 1.000 | 4.26 | 100.00 | 100.00 | 0.001 | 0.927-1.000 |
MiR-145 | 0.941 | 0.26 | 91.67 | 88.00 | 0.001 | 0.834-0.988 |
MiR-382 | 0.952 | 0.24 | 87.50 | 92.00 | 0.001 | 0.849-0.992 |
8-hydroxy-2′-deoxyguanosine | 0.627 | 3232 | 79.17 | 56.00 | 0.125 | 0.477-0.761 |
Cancer antigen 15-3 | 0.768 | 235.3 | 87.50 | 68.00 | 0.001 | 0.626-0.877 |
- Citation: El-Toukhy SE, Nabih HK, Kamel MM, Elmasry H, El-Daly SM. Circulating microRNAs and serum proteins in breast cancer patients: Diagnostic relevance and grade-specific expression patterns. World J Exp Med 2025; 15(3): 108034
- URL: https://www.wjgnet.com/2220-315X/full/v15/i3/108034.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i3.108034